290 related articles for article (PubMed ID: 22342021)
1. Generic drugs in dermatology: part I.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):343.e1-8; quiz 351-2. PubMed ID: 22342021
[TBL] [Abstract][Full Text] [Related]
2. Generic drugs in dermatology: part II.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
[TBL] [Abstract][Full Text] [Related]
3. Brand name versus generic drugs: the ethical quandary in caring for our sophisticated patients while trying to reduce health-care costs: facts and controversies.
Payette M; Grant-Kels JM
Clin Dermatol; 2013; 31(6):772-6. PubMed ID: 24160285
[TBL] [Abstract][Full Text] [Related]
4. Generic drugs--safe, effective, and affordable.
Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
[TBL] [Abstract][Full Text] [Related]
5. Rising drug costs: the impact on dermatology.
Rico MJ
Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
[TBL] [Abstract][Full Text] [Related]
6. The rise of the generic drug market and its implications for dermatology.
Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
[TBL] [Abstract][Full Text] [Related]
7. Dissecting drug pricing: Supply chain, market, and nonmarket trends impacting clinical dermatology.
Nguyen HP; Go JA; Barbieri JS; Stough D; Stoff BK; Forman HP; Bolognia JL; Albrecht J;
J Am Acad Dermatol; 2020 Aug; 83(2):691-699. PubMed ID: 32330637
[No Abstract] [Full Text] [Related]
8. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
Alghanem N; Abokwidir M; Fleischer AB; Feldman SR; Alghanem W
J Dermatolog Treat; 2017 Mar; 28(2):119-128. PubMed ID: 27241622
[TBL] [Abstract][Full Text] [Related]
9. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
Rosenberg ME; Rosenberg SP
JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
[TBL] [Abstract][Full Text] [Related]
10. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
Li DG; Joyce C; Mostaghimi A
JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
[TBL] [Abstract][Full Text] [Related]
11. The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money.
Shrank WH; Choudhry NK; Liberman JN; Brennan TA
Health Aff (Millwood); 2011 Jul; 30(7):1351-7. PubMed ID: 21734210
[TBL] [Abstract][Full Text] [Related]
12. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
Argumosa A; Herranz JL
Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
[TBL] [Abstract][Full Text] [Related]
13. The generics in transplantation and the rules on their use.
Masri M
Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
[TBL] [Abstract][Full Text] [Related]
14. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
Fischer MA; Avorn J
Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
[TBL] [Abstract][Full Text] [Related]
15. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
16. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
17. The state and consequences of dermatology drug prices in the United States.
Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
[No Abstract] [Full Text] [Related]
18. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.
Rodin HA; Heaton AH; Wilson AR; Garrett NA; Plocher DW
Am J Manag Care; 2009 Dec; 15(12):881-8. PubMed ID: 20001169
[TBL] [Abstract][Full Text] [Related]
19. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
[TBL] [Abstract][Full Text] [Related]
20. Generic medications for you, but brand-name medications for me.
Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]